408 related articles for article (PubMed ID: 38689325)
1. Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis.
Dadgar N; Sherry C; Zimmerman J; Park H; Lewis C; Donnenberg A; Zaidi AH; Fan Y; Xiao K; Bartlett D; Donnenberg V; Wagner PL
J Transl Med; 2024 Apr; 22(1):402. PubMed ID: 38689325
[TBL] [Abstract][Full Text] [Related]
2. Surgery and intracavitary chemotherapy for peritoneal carcinomatosis from colorectal origin.
Ceelen W; Van Nieuwenhove Y; Pattyn P
Acta Gastroenterol Belg; 2008; 71(4):373-8. PubMed ID: 19317277
[TBL] [Abstract][Full Text] [Related]
3. Targeting carcinoma-associated mesothelial cells with antibody-drug conjugates in ovarian carcinomatosis.
Pascual-Antón L; Sandoval P; González-Mateo GT; Kopytina V; Tomero-Sanz H; Arriero-País EM; Jiménez-Heffernan JA; Fabre M; Egaña I; Ferrer C; Simón L; González-Cortijo L; Sainz de la Cuesta R; López-Cabrera M
J Pathol; 2023 Oct; 261(2):238-251. PubMed ID: 37555348
[TBL] [Abstract][Full Text] [Related]
4. Characterizing the Immune Environment in Peritoneal Carcinomatosis: Insights for Novel Immunotherapy Strategies.
Wagner PL; Knotts CM; Donneberg VS; Dadgar N; Pico CC; Xiao K; Zaidi A; Schiffman SC; Allen CJ; Donnenberg AD; Bartlett DL
Ann Surg Oncol; 2024 Mar; 31(3):2069-2077. PubMed ID: 37996643
[TBL] [Abstract][Full Text] [Related]
5. The role of the peritoneal microenvironment in the pathogenesis of colorectal peritoneal carcinomatosis.
Demuytere J; Ceelen W; Van Dorpe J; Hoorens A
Exp Mol Pathol; 2020 Aug; 115():104442. PubMed ID: 32305340
[TBL] [Abstract][Full Text] [Related]
6. CD44-targeting for antitumor drug delivery: a new SN-38-hyaluronan bioconjugate for locoregional treatment of peritoneal carcinomatosis.
Serafino A; Zonfrillo M; Andreola F; Psaila R; Mercuri L; Moroni N; Renier D; Campisi M; Secchieri C; Pierimarchi P
Curr Cancer Drug Targets; 2011 Jun; 11(5):572-85. PubMed ID: 21486216
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal chemotherapy against peritoneal carcinomatosis: current status and future perspective.
Kitayama J
Surg Oncol; 2014 Jun; 23(2):99-106. PubMed ID: 24721661
[TBL] [Abstract][Full Text] [Related]
8. Therapeutics target of CXCR4 and its downstream in peritoneal carcinomatosis of gastric cancer.
Koizumi K; Kato S; Sakurai H; Hashimoto I; Yasumoto K; Saiki I
Front Biosci (Schol Ed); 2012 Jan; 4(1):269-76. PubMed ID: 22202059
[TBL] [Abstract][Full Text] [Related]
9. Metastatic appendiceal mucinous adenocarcinoma to well-differentiated diffuse mesothelioma of the peritoneal cavity: a mimicker of florid mesothelial hyperplasia in association with neoplasms.
Tran TA; Holloway RW; Finkler NJ
Int J Gynecol Pathol; 2008 Oct; 27(4):526-30. PubMed ID: 18753969
[TBL] [Abstract][Full Text] [Related]
10. Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review.
van Baal JOAM; van Noorden CJF; Nieuwland R; Van de Vijver KK; Sturk A; van Driel WJ; Kenter GG; Lok CAR
J Histochem Cytochem; 2018 Feb; 66(2):67-83. PubMed ID: 29164988
[TBL] [Abstract][Full Text] [Related]
11. The Role of Hyperthermic Intraperitoneal Chemotherapy for Non-colorectal Peritoneal Surface Malignancies.
Morris MC; Cloyd JM; Hays J; Patel SH
J Gastrointest Surg; 2021 Jan; 25(1):303-318. PubMed ID: 32808135
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.
Koppe MJ; Boerman OC; Oyen WJ; Bleichrodt RP
Ann Surg; 2006 Feb; 243(2):212-22. PubMed ID: 16432354
[TBL] [Abstract][Full Text] [Related]
13. Mesothelial cells differentiate into fibroblast-like cells under the scirrhous gastric cancer microenvironment and promote peritoneal carcinomatosis in vitro and in vivo.
Lv ZD; Wang HB; Dong Q; Kong B; Li JG; Yang ZC; Qu HL; Cao WH; Xu HM
Mol Cell Biochem; 2013 May; 377(1-2):177-85. PubMed ID: 23392771
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis: Our Initial Experience.
Bartoş A; Bartoş D; Raluca S; Mitre C; Hadade A; Iancu I; Cioltean C; Iancu C; Militaru C; Părău A; Breazu C
Chirurgia (Bucur); 2019; 114(2):222-233. PubMed ID: 31060655
[No Abstract] [Full Text] [Related]
15. Peritoneal carcinomatosis of gastrointestinal origin: natural history and treatment options.
Davies JM; O'Neil B
Expert Opin Investig Drugs; 2009 Jul; 18(7):913-9. PubMed ID: 19548850
[TBL] [Abstract][Full Text] [Related]
16. Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study.
Nowacki M; Alyami M; Villeneuve L; Mercier F; Hubner M; Willaert W; Ceelen W; Reymond M; Pezet D; Arvieux C; Khomyakov V; Lay L; Gianni S; Zegarski W; Bakrin N; Glehen O
Eur J Surg Oncol; 2018 Jul; 44(7):991-996. PubMed ID: 29526367
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of peritoneal carcinomatosis: current treatment modalities.
Kulu Y; Müller-Stich B; Büchler MW; Ulrich A
Langenbecks Arch Surg; 2014 Jan; 399(1):41-53. PubMed ID: 24249036
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal carcinomatosis with intraperitoneal immunotherapy: current treatment options and perspectives.
Wei GX; Du Y; Zhou YW; Li LJ; Qiu M
Expert Rev Gastroenterol Hepatol; 2022 Sep; 16(9):851-861. PubMed ID: 36107723
[TBL] [Abstract][Full Text] [Related]
19. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.
Wang R; Song S; Harada K; Ghazanfari Amlashi F; Badgwell B; Pizzi MP; Xu Y; Zhao W; Dong X; Jin J; Wang Y; Scott A; Ma L; Huo L; Vicente D; Blum Murphy M; Shanbhag N; Tatlonghari G; Thomas I; Rogers J; Kobayashi M; Vykoukal J; Estrella JS; Roy-Chowdhuri S; Han G; Zhang S; Mao X; Song X; Zhang J; Gu J; Johnson RL; Calin GA; Peng G; Lee JS; Hanash SM; Futreal A; Wang Z; Wang L; Ajani JA
Gut; 2020 Jan; 69(1):18-31. PubMed ID: 31171626
[TBL] [Abstract][Full Text] [Related]
20. Systemic and peritoneal inflammatory response after laparoscopic-assisted gastrectomy and the effect of inflammatory cytokines on adhesion of gastric cancer cells to peritoneal mesothelial cells.
Yu G; Tang B; Yu PW; Peng ZH; Qian F; Sun G
Surg Endosc; 2010 Nov; 24(11):2860-70. PubMed ID: 20419322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
